ST. PAUL, Minn. People with Parkinson's disease who go to a neurologist for their care are more likely to live longer, less likely to be placed in a nursing home and less likely to break a hip than people who go to a primary care physician, according to a study published in the August 10, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology (AAN).

The study also found that women and minorities were less likely to see a neurologist than men and Caucasians, even after adjusting for factors such as age, socioeconomic status and other health conditions.

"If these findings are confirmed in future studies, they will have important policy implications," said James F. Burke, MD, of the University of Michigan in Ann Arbor and a member of the American Academy of Neurology, who wrote an editorial about the study. "Disparities in access to care should become a pressing priority if these limits to access are associated with worse outcomes. Policy changes could focus on improving access to neurologists or on improving the knowledge and care given by primary care physicians."

For the study, researchers examined the records of everyone on Medicare with a new diagnosis of Parkinson's disease who was seen in an outpatient clinic during 2002. Of the 138,000 people who were diagnosed with Parkinson's disease that year, 68 percent were seen by a neurologist from 2002 to 2005.

Those seen by a neurologist were 20 percent less likely to die over a six-year period than those seen by a primary care physician. They were also 20 percent less likely to be placed in a nursing home and 14 percent less likely to have a broken hip.

Women were 22 percent less likely to see a neurologist than men, and minorities were 17 percent less likely to see a neurologist than Caucasians.

Study author Allison Wright Willis, MD, of Washington University School of Medicine in St. Louis and a member of the A
'/>"/>

• AIDS/HIV
• Bioinformatics
• Biotechnology
• Biochemistry
• Cancer
• Cell Biology
• Developmental Biology
• Ecology
• Environment
• Evolution
• Food Technology
• Gene
• Genetics
• Genomics
• Health/Medicine
• Immunology
• Microarray
• Microbiology
• Molecular
• Marine Biology
• Nanobiotechnology
• Neurobiology
• Plant Sciences
• Stem Cell
• Systems Biology
• Virus
• Women Health

• Abortion
• Aches
• ADHD
• Addiction
• Alcohol
• Allergy
• Alternative Medicine
• Alzheimer's Dementia
• Anxiety/Stress
• Arthritis
• Autism
• Bacteria
• Blood
• Bird Flu/Avian Flu
• Bones
• Breast Cancer
• Cancer
• Cardiovascular
• Cervical Cancer
• Chikungunya
• Cholesterol
• Clinical Trials
• Colorectal Cancer
• Conferences
• Crohn's
• Cystic Fibrosis
• Dengue
• Dentistry
• Depression
• Diabetes
• Drug
• Eating Disorders
• Education
• Epilepsy
• Erectile Dysfunction
• Eye Health/Blindness
• Fertility
• Flu/Cold
• GastroIntestinal
• Genetics
• Gout
• Headache/Migraine
• Hearing/Deafness
• HIV/AIDS
• Huntington's Disease
• Hypertension
• Immune System/Vaccines
• Insurance
• Infectious Diseases
• Irritable-Bowel Syndrome
• Internet
• Leukemia
• Lifestyle
• Liver Disease/Hepatitis
• Lung Cancer
• Lupus
• Mad Cow Disease
• Medical Devices
• Medical Students/Training
• Medicare/Medicaid
• Medico
• Men's health
• Mental Health
• MRI/Ultrasound
• MRSA/Drug Resistance
• Multiple Sclerosis
• Muscular Dystrophy
• Neurology
• Nursing
• Nutrition/Diet
• Obesity/Weight Loss
• Pain/Anesthetics
• Parkinson's Disease
• Pediatrics/Children's Health
• Pharma/Biotech Industry
• Pharmacy/Pharmacists
• Pregnancy
• Premature
• Prostate
• Psychology/Psychiatry
• Rehabilitation
• Respiratory/Asthma
• SARS
• Schizophrenia
• Seniors/Aging
• Sexual Health
• Sleep/Sleep Disorders
• Smoking
• Statins
• Stem Cell Research
• Stroke
• Surgery
• Transplants/Organ Donations
• Viruses
• Water - Air Quality
• Women's Health